Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00192621
What this trial is testing

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Who this might be right for
HIV InfectionsDyslipidemiasGlucose Metabolism Disorders+3 more
Kirby Institute 50
Early research (Phase 1)Study completedNCT03095638
What this trial is testing

Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of Dolutegravir

Who this might be right for
HIV Infections
ViiV Healthcare 38
Large-scale testing (Phase 3)Study completedNCT02383108
What this trial is testing

Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children

Who this might be right for
HIV Infection
PENTA Foundation 318
Not applicableStudy completedNCT03025165
What this trial is testing

A Comparison of Different Community Models of ART Delivery Amongst Stable HIV+ Patients in Two Urban Settings in Zambia

Who this might be right for
HIV Infections
HIV Prevention Trials Network 2,526
Testing effectiveness (Phase 2)Looking for participantsNCT05580458
What this trial is testing

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

Who this might be right for
Herpes Zoster
National Institute of Allergy and Infectious Diseases (NIAID) 225
Testing effectiveness (Phase 2)Study completedNCT04871113
What this trial is testing

Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults

Who this might be right for
HIV Infections
ViiV Healthcare 62
Not applicableStudy completedNCT00002203
What this trial is testing

Two Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Glaxo Wellcome
Large-scale testing (Phase 3)WithdrawnNCT02069834
What this trial is testing

Dolutegravir + Rilpivirine Switch Study (DORISS)

Who this might be right for
HIV InfectionHAART-treatedVirologically Controlled
Nantes University Hospital
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05597800
What this trial is testing

Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome

Who this might be right for
NSCLC Stage IVHIVHBV+2 more
Universita di Verona 105
Post-approval studies (Phase 4)Study completedNCT00556634
What this trial is testing

Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage

Who this might be right for
HIV-1 InfectionHIV Infection
Sociedad Andaluza de Enfermedades Infecciosas 114
Testing effectiveness (Phase 2)UnknownNCT00002219
What this trial is testing

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

Who this might be right for
HIV Infections
Gilead Sciences 36
Not applicableStudy completedNCT04514016
What this trial is testing

Cross Sectional CFAR HIV/COVID-19 Study

Who this might be right for
SARS-CoV InfectionCovid19
University of Miami 64
Not applicableStudy completedNCT00002028
What this trial is testing

A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir)

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT00320307
What this trial is testing

Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects

Who this might be right for
HIV Infection
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Ended earlyNCT06032546
What this trial is testing

Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382

Who this might be right for
Human Immuno-deficiency Virus (HIV) Disease
AbbVie 163
Not applicableStudy completedNCT00002247
What this trial is testing

Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche 225
Not applicableStudy completedNCT01258582
What this trial is testing

Two Approaches to Routine HIV Testing in a Hospital Emergency Department

Who this might be right for
HIV Infections
Massachusetts General Hospital 1,651
Testing effectiveness (Phase 2)Study completedNCT02660710
What this trial is testing

Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell LymphomaHIV
UNC Lineberger Comprehensive Cancer Center 39
Early research (Phase 1)WithdrawnNCT01927835
What this trial is testing

Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Next Page